← Back to Patent Explorer
US4787974A Expired / Lapsed US ⏱️ 0.0 years remaining

Blood purification

Assignee: Hemex Inc
•
Filing: 1987-10-22
•
Granted: 1988-11-29
•
Expires: 2007-10-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Extracorporeal apparatus for selective removal of pathogenic factors, i.e. antigens, from blood by circulating the blood through hollow fibers which, exterior to the lumen are in proximity to antibodies, i.e. proteins having strong biospecific activity for the pathogenic factors. In some situations, the antibody is segregated in a liquid medium outside the hollow fiber to improve mass transfer and the antigen penetrates the ultrafilter wall of the fiber to join the antibody.

Inventors

  • 👤 Clara M. Ambrus
  • 👤 Csaba Horvath

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 00:51
CPC Classifications
B; B01; B01D; B01D61/00; B01D61/14; B01D61/18; A; A61; A61M; A61M1/00; A61M1/34; A61M1/3472; A61M1/3475; A61M1/3486; B01D15/00; B01D63/00; B01D63/02; B01D63/031; B01D69/00; B01D69/14; B01D69/141; B01D69/142; B01D69/144; B01J; B01J45/00; A61M2205/00; A61M2205/36; A61M2205/3606; A61M2205/366; B01D15/08; B01D15/26; B01D15/38; B01D15/3804; B01D15/3809; B01D2311/00; B01D2311/26; B01D2311/2626

Claims Analysis

Total Claims: 21
Claim 1
Independent Claim 122 words
Apparatus for removing selected antigens from a physiological fluid comprising an anisotropic membrane surface of the type having a retentive skin side and a porous substrate exterior side and forming a diffusion barrier permeable to water and said selected antigens but substantially impermeable to formed elements of blood, a flow path forming means for directing said fluid to flow in contact with the retentive skin side of said membrane; pump means to move said blood along said flow-path, said pump means being the only blood-moving means of said apparatus; a closed, constant-volume compartment enclosing the exterior of said membranes; and an immunoreactive scavenging agent effective to scavenge predetermined antigens from said blood immobilized on the porous substrate side of said anisotropic membrane.
Claim 2
Dependent Claim 122 words
Apparatus for removing selected antigens from a physiological fluid comprising an anisotropic membrane surface of the type having a retentive skin side and a porous substrate exterior side and forming a diffusion barrier permeable to water and said selected antigens but substantially impermeable to formed elements of blood, a flow path forming means for directing said fluid to flow in contact with the retentive skin side of said membrane; pump means to move said blood along said flow-path, said pump means being the only blood-moving means of said apparatus; a closed, constant-volume compartment enclosing the exterior of said membranes; and an immunoreactive scavenging agent effective to scavenge predetermined antigens from said blood immobilized on the porous substrate side of said anisotropic membrane.
Claim 3
Dependent Claim 40 words
Apparatus as defined in claim 1 wherein said membrane barrier surface is in the form of the interior surfaces of a plurality of closely spaced tubes and wherein said agent is positioned within the porous exterior portion of said tubes.
Claim 4
Dependent Claim 11 words
Apparatus as defined in claim 2 wherein said antigen is digoxin.
Claim 5
Dependent Claim 12 words
Apparatus as defined in claim 2 wherein said antigen is a barbiturate.
Claim 6
Dependent Claim 13 words
Apparatus as defined in claim 2 wherein said antigen is a propoxyphene napsylate.
Claim 7
Dependent Claim 13 words
Apparatus as defined in claim 2 wherein said antigen is an antigen-antibody complex.
Claim 8
Dependent Claim 14 words
Apparatus as defined in claim 6 wherein said antigen-antibody complex is an insulin antibody.
Claim 9
Dependent Claim 11 words
Apparatus as defined in claim 2 wherein said antigen is quinidine.
Claim 10
Dependent Claim 16 words
Apparatus as defined in claim 2 wherein said antigen is bilirubin and said antibody is albumin.
Claim 11
Dependent Claim 12 words
Apparatus as defined in claim 2 wherein said antigen is immunoglobulin G.
Claim 12
Dependent Claim 12 words
Apparatus as defined in claim 2 wherein said antigen is a bacteria.
Claim 13
Dependent Claim 11 words
Apparatus as defined in claim 2 wherein said antigen is 1-thyroxin.
Claim 14
Dependent Claim 30 words
Apparatus as defined in claim 1 comprising additionally an exterior chamber around said constant volume compartment forming means to confine a temperature-control fluid to maintain said compartment at constant volume.
Claim 15
Dependent Claim 40 words
Apparatus as defined in claim 13 wherein said membrane barrier surface is in the form of the interior surfaces of a plurality of closely spaced tubes and wherein said agent is positioned within the porous exterior portion of said tubes.
Claim 16
Dependent Claim 29 words
Apparatus as defined in claim 1 wherein said antigen is about 100,000 Daltons and wherein said immunoreactive scavenging agent is attached to said membrane via a molecular space segment.
Claim 17
Dependent Claim 14 words
Apparatus as defined in claim 15 wherein said spacer material is formed of albumin.
Claim 18
Dependent Claim 13 words
Apparatus as defined in claim 15 wherein said immobilized scavenging agent is albumin.
Claim 19
Dependent Claim 37 words
Apparatus as defined in claim 1 wherein said immunoreactive scavenging agent is in the form of an antibody which is chemically reacted to a high-molecular weight substrate to inhibit diffusion from said porous substrate of said membrane.
Claim 20
Dependent Claim 25 words
Apparatus as defined in claim 18 wherein said high molecular weight substrate is silica gel or dextran or a polymer formed of said scavenging agent.
Claim 21
Dependent Claim 13 words
Apparatus as defined in claim 18 wherein said immobilized scavenging agent is albumin.

References Cited (Backward Citations)

US4375414A Cited
US3930105A Cited
US4266026A Cited
US4323457A Cited
US4247393A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-11-29 1992-05-30 1992-11-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-11-29 1996-05-30 1996-11-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-11-29 2000-05-30 2000-11-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag